Skip to main content
Watch Insiders
GRALHealthcare

GRAIL Inc. (GRAL) Insider Trading

In the last 90 days, 3 GRAIL Inc. (GRAL) insiders reported no open-market purchases and 7 sales totaling $14,832,794. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 15, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 15, 2026Joshua J. OfmanChief Executive OfficerSale20,000$136.85$2,736,944
Oct 5, 2026Andrew John PartridgeChief Growth OfficerSale7,873$146.39$1,152,528
Oct 5, 2026Aaron FreidinChief Financial OfficerSale23,619$146.39$3,457,585
Sep 21, 2026Aaron FreidinChief Financial OfficerSale4,100$93.34$382,679
Sep 21, 2026Joshua J. OfmanChief Executive OfficerSale61,452$97.74$6,006,380
Aug 27, 2026Joshua J. OfmanChief Executive OfficerSale5,000$85.02$425,098
Aug 27, 2026Aaron FreidinChief Financial OfficerSale7,900$85.01$671,579
Jun 4, 2026Andrew John PartridgeChief Growth OfficerSale1,491$61.08$91,070

Common questions

GRAL insider trading FAQ

Are GRAL insiders buying or selling?
Over the last 90 days, GRAL insiders were net sellers, reporting $0.00 of open-market purchases and $14,832,794 of sales.
When was the last GRAL insider purchase?
No open-market insider purchase of GRAIL Inc. stock was reported in the last 90 days.
Where does GRAL insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that GRAIL Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.